Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Goodwill & Intangibles data on record, last reported at $572.2 million in Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $572.2 million; the TTM value through Sep 2025 reached $572.2 million, changed N/A, while the annual FY2024 figure was $590.7 million, 3.69% down from the prior year.
  • Goodwill & Intangibles reached $572.2 million in Q3 2025 per AMPH's latest filing, down from $628.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $628.9 million in Q2 2025 and bottomed at $2.9 million in Q3 2022.
  • Average Goodwill & Intangibles over 5 years is $253.2 million, with a median of $45.1 million recorded in 2021.
  • Peak YoY movement for Goodwill & Intangibles: crashed 93.59% in 2022, then surged 20384.71% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $38.9 million in 2021, then grew by 12.78% to $43.8 million in 2022, then skyrocketed by 1298.97% to $613.3 million in 2023, then decreased by 3.69% to $590.7 million in 2024, then decreased by 3.12% to $572.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $572.2 million in Q3 2025, $628.9 million in Q2 2025, and $590.7 million in Q4 2024.